SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001750316-18-000001
Filing Date
2018-10-24
Accepted
2018-10-24 13:42:44
Documents
1
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1453
  Complete submission text file 0001750316-18-000001.txt   3097
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Issuer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 812 MAPLEWOOD ROAD WAYNE PA 19087
Business Address
Phelan Nancy R. (Reporting) CIK: 0001750316 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-13789 | Film No.: 181136107